MYCN and neuroblastoma: However, it was observed that MYCN is a transcriptional regulator of MRE11, RAD50, and NBS1 [167], and the MRN complex contributes to the control of DNA damage levels compatible with tumor cell survival, so that high MRE11 expression is related to reduced overall survival in primary human neuroblastoma [155].